Ｂ型慢性肝疾患治療薬「ベムリディ錠25mg」の中国国内で確認された偽造品について｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000170678.htmlBundle the HTML, screenshot, summaries, and metadata into one ZIP file. The first export request adds an external RFC 3161 timestamp before download.
Ｂ型慢性肝疾患治療薬「ベムリディ錠25mg」の中国国内で確認された偽造品について｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces the discovery of counterfeit B-type chronic hepatitis treatment drug "Bemlidia Tablets 25mg" in China. The counterfeit products have Japanese labels on the packaging and bottle. Currently, no counterfeits have been confirmed in Japan and no health damage has been reported. The Ministry of Health, Labour and Welfare urges citizens to contact local health departments or prefectural governments if they encounter such counterfeits, and advises against distribution, dispensing, or consumption. Details on identifying genuine products are available on the manufacturer's website.
